<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362794">
  <stage>Registered</stage>
  <submitdate>23/07/2012</submitdate>
  <approvaldate>24/07/2012</approvaldate>
  <actrnumber>ACTRN12612000783820</actrnumber>
  <trial_identification>
    <studytitle>The glycaemic index of infant formula products</studytitle>
    <scientifictitle>The glycaemic index of infant formula products assessed in healthy individuals</scientifictitle>
    <utrn>U1111-1132-8842</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Diabetes</healthcondition>
    <healthcondition>glycaemic index</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The participants consume an infant formula and this is compared to the glucose response in the blood for 25g glucose. There are 17 infant formula's, made up from a powder mixed with water and 3 glucoses in all. 21.3g infant formula powder is added to 220ml water. Each formula is consumed once only. The participants come in on 20 seperate occassions, usually 2 to 3 times a week. The formula's are mixtures of lactose, glucose solids, dextrose, maltodextrin, galacto-oligosaccharides, fructo-oligosaccharides, oat fibre, apple fibre, docosahexanoic acid, arachidonic acid, alpha-linoleic acid and linoleic acid. Response is monitored for 120 minutes after consumption.</interventions>
    <comparator>25g glucose in 220ml water. This is measured on three seperate occassions. Response is monitored for 120 minutes after consumption.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The glycaemic index of each of the infant formula's. This is the incremental area under the blood glucose curve of the formula in relation to a 25 g glucose reference</outcome>
      <timepoint>-5,0,15,30,45,60,90,120 minutes</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>healthy individuals with a fasting blood glucose below 5.6 mmol/L</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>64</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>fasting blood glucose above 5.6mmol/L
smoking</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects respond to newspaper advertisements. They are randomised to the order in which they receive the infant formulas. Allocation is not concealed.</concealment>
    <sequence>Simple randomisation using a randomization table created by computer software.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/07/2012</anticipatedstartdate>
    <actualstartdate>20/07/2012</actualstartdate>
    <anticipatedenddate>30/07/2012</anticipatedenddate>
    <actualenddate>30/07/2012</actualenddate>
    <samplesize>13</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Canterbury</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>New Zealand Institute for Plant &amp; Food Research</primarysponsorname>
    <primarysponsoraddress>Private Bag 4704, Christchurch 8140, Canterbury</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Nutricia</fundingname>
      <fundingaddress>37 Banks Road, Mt Wellington, Auckland 1060</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Government body</othercollaboratortype>
      <othercollaboratorname>Lipid and Diabetes Research Group</othercollaboratorname>
      <othercollaboratoraddress>40 Stewart Street, Christchurch 8011, Canterbury</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is to evaluate to blood glucose response of a variety of infant formula products. The glycaemic index measures how blood glucose changes after a portion of food that contains 50g avaliable carbohydrate has been eaten. Teh benefit of the system is that it allows us to classify whether a food causes a large increase in blood glcuose after it is eaten, or if its response is lower and lasts for longer. Blood glucose control is especially important for people with diabetes as high levels of circulating glucose can cause cellular damage and increase their risk of coronary heart disease. Low GI foods will produce a smaller, longer lasting increase in blood glucose and hence consuming a diet high in low GI foods will improve blood glucose control in people with diabetes</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Nil</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Upper South A Regional Ethics Committee</ethicname>
      <ethicaddress>C/_ Ministry Of Health,
PO Box 3877, Christchurch 8140, Canterbury</ethicaddress>
      <ethicapprovaldate>1/06/2011</ethicapprovaldate>
      <hrec>CTB/04/02/007</hrec>
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Alison Wallace</name>
      <address>Private Bag 4704, Christchurch 8140, Canterbury</address>
      <phone>+6433259638</phone>
      <fax>+6433252074</fax>
      <email>alison.wallace@plantandfood.co.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alison Wallace</name>
      <address>Private Bag 4704, Christchurch 8140, Canterbury</address>
      <phone>+6433259638</phone>
      <fax>+6433252074</fax>
      <email>alison.wallace@plantandfood.co.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Alison Wallace</name>
      <address>Private Bag 4704, Christchurch 8140, Canterbury</address>
      <phone>+6433259638</phone>
      <fax>+6433252074</fax>
      <email>alison.wallace@plantandfood.co.nz</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alison Wallace</name>
      <address>New Zealand Institute for Plant &amp; Food Research Ltd
Private Bag 4704 Christchurch 8140</address>
      <phone>+6433256400</phone>
      <fax>+6433252074</fax>
      <email>alison.wallace@plantandfood.co.nz</email>
      <country>New Zealand</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>